Hydroxychloroquine

August 2021 JDD Issue | Special Focus on Psoriasis
PSORIASIS
by NEXT STEPS IN DERM TEAM on
With a special focus on psoriasis, the August issue of the Journal of Drugs in Dermatology features an outstanding editorial line-up with articles, features, and case reports on topics ranging from antihistamines in psoriasis, facial erythema in rosacea, management of AKs, to herpes zoster following COVID-19 vaccination, cutaneous angiosarcoma of the scalp, and everything in between! Straight fr …
Treating Alopecia in Skin of Color Patients: How to Arrest Loss and Promote Regrowth
alopecia in soc
by Edita Newton, MD on
Can you improve your culturally-competent hair loss consultation? Would you like to grow your toolbox for comprehensive alopecia treatment? If so, you are in the right place! Hair loss is a frequent concern for patients visiting the dermatologist, especially in patients with pigmented skin types. Kinky or coiled hair has an innate fragility that makes African Americans especially prone to hair …
Skin Findings in COVID-19 Patients
Skin Findings in COVID-19 Patients
by ANNA H. CHACON, MD on
The skin findings in COVID-19 patients include a morbilliform rash, urticaria, vesicular eruptions, acral lesions (COVID toes), livedoid eruptions, and other nonspecific skin findings. Skin findings of COVID-19 disease are similar to the cutaneous findings in other viral infections. Some of the skin findings are more commonly associated with COVID-19 infection than with other viruses sugg …
Frontal Fibrosing Alopecia Presenting as Androgenetic Alopecia in an African American Woman
African American Woman with frontal fibrosis alopecia
by NEXT STEPS IN DERM TEAM on
Frontal fibrosing alopecia (FFA) is a primary lymphocytic cicatricial alopecia that is currently regarded as a variant of lichen planopilaris. FFA has historically been considered rare in black patients, in whom traction alopecia, central centrifugal cicatricial alopecia, and androgenetic alopecia are frequently assumed to be more common. JDD author Kimberly Huerth, MD, ME describes a case of FFA …
Hydroxychloroquine, Pentoxifylline, and Colchicine: Off-Label is ON in Dermatology
Hydroxychloroquine, Pentoxifylline, and Colchicine: Off-Label is ON in Dermatology!
by NEXT STEPS IN DERM TEAM on
So many diseases, so few FDA approved indications. Between the mind-numbing time and cost from bench to bottle, it is no surprise that dermatologists, as masters of the integument are the off-label bandits, marrying their wealth of knowledge on the pathophysiology of skin diseases to the mechanisms by which medications work to create an evidenced-based armament of therapies for both common and rar …